Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marije K Verheul

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Arthritis Research & Therapy|November 4, 2017
Anti-carbamylated protein antibodies precede disease onset in monkeys with collagen-induced arthritisMarije K Verheul, Michel P M Vierboom, Bert A 't Hart, et al.
Rheumatology (Oxford, England)|July 17, 2015
Anti-carbamylated protein antibodies in rheumatoid arthritis patients of Asian descentMarije K Verheul, Kazuko Shiozawa, E W Nivine Levarht, et al.
Arthritis Research & Therapy|April 19, 2015
Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damageMikael Brink, Marije K Verheul, Johan Rönnelid, et al.
Arthritis Research & Therapy|February 11, 2016
Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritisMikael Brink, Monika Hansson, Linda Mathsson-Alm, et al.
Immunity & Ageing : I & A|September 13, 2024
Repeated COVID-19 mRNA vaccination results in IgG4 class switching and decreased NK cell activation by S1-specific antibodies in older adultsAnne T Gelderloos, Marije K Verheul, Irene Middelhof, et al.
Annals of the Rheumatic Diseases|October 8, 2015
Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis RegisterJennifer H Humphreys, Marije K Verheul, Anne Barton, et al.
Journal of Autoimmunity|March 15, 2017
Identification of carbamylated alpha 1 anti-trypsin (A1AT) as an antigenic target of anti-CarP antibodies in patients with rheumatoid arthritisMarije K Verheul, Alvin Yee, Andrea Seaman, et al.
Arthritis Research & Therapy|August 4, 2016
MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RFDebbie M Boeters, Wouter P Nieuwenhuis, Marije K Verheul, et al.
Rheumatology (Oxford, England)|October 3, 2017
The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgiaRobin M Ten Brinck, Hanna W van Steenbergen, Myrthe A M van Delft, et al.
Frontiers in Immunology|January 11, 2021
Vi-Vaccinations Induce Heterogeneous Plasma Cell Responses That Associate With Protection From Typhoid FeverDeborah L Cross, Marije K Verheul, Michael D Leipold, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Arthritis Research & Therapy|November 4, 2017
Anti-carbamylated protein antibodies precede disease onset in monkeys with collagen-induced arthritisMarije K Verheul, Michel P M Vierboom, Bert A 't Hart, et al.
Rheumatology (Oxford, England)|July 17, 2015
Anti-carbamylated protein antibodies in rheumatoid arthritis patients of Asian descentMarije K Verheul, Kazuko Shiozawa, E W Nivine Levarht, et al.
Arthritis Research & Therapy|April 19, 2015
Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damageMikael Brink, Marije K Verheul, Johan Rönnelid, et al.
Arthritis Research & Therapy|February 11, 2016
Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritisMikael Brink, Monika Hansson, Linda Mathsson-Alm, et al.
Immunity & Ageing : I & A|September 13, 2024
Repeated COVID-19 mRNA vaccination results in IgG4 class switching and decreased NK cell activation by S1-specific antibodies in older adultsAnne T Gelderloos, Marije K Verheul, Irene Middelhof, et al.
Annals of the Rheumatic Diseases|October 8, 2015
Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis RegisterJennifer H Humphreys, Marije K Verheul, Anne Barton, et al.
Journal of Autoimmunity|March 15, 2017
Identification of carbamylated alpha 1 anti-trypsin (A1AT) as an antigenic target of anti-CarP antibodies in patients with rheumatoid arthritisMarije K Verheul, Alvin Yee, Andrea Seaman, et al.
Arthritis Research & Therapy|August 4, 2016
MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RFDebbie M Boeters, Wouter P Nieuwenhuis, Marije K Verheul, et al.
Rheumatology (Oxford, England)|October 3, 2017
The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgiaRobin M Ten Brinck, Hanna W van Steenbergen, Myrthe A M van Delft, et al.
Frontiers in Immunology|January 11, 2021
Vi-Vaccinations Induce Heterogeneous Plasma Cell Responses That Associate With Protection From Typhoid FeverDeborah L Cross, Marije K Verheul, Michael D Leipold, et al.
Pageof 3